Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-11 of 11 for your search:
Cancer Type/Condition:
Brain tumor, child: Brain stem glioma
Stage/Subtype:
untreated childhood brain stem glioma
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Any age
Sponsor:
Other
Protocol IDs:
MSKCC-05122
, NCT00445965
2.
Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
3368
, NCT00576537
3.
External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
3 to 21
Sponsor:
Other
Protocol IDs:
09-014
, NCT01012609
4.
Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
3 to 21
Sponsor:
NCI
Protocol IDs:
JHOC-J0423
, JHOC-04041906, NCT00095771
5.
Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
3 to 21
Sponsor:
NCI
Protocol IDs:
PBTC-021
, NCT00357253
6.
Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
6657
, NCT00576641
7.
Bone Marrow Radiation Therapy Followed by Busulfan, Melphalan, Thiotepa, and an Autologous Stem Cell Transplant in Treating Patients With High-Risk or Relapsed Solid Tumors
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Diagnostic, Treatment
Status:
Active
Age:
70 and under
Sponsor:
NCI
Protocol IDs:
UMN-2005LS023
, UMN-2005LS023, UMN-MT2004-30, NCT00623077
8.
Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
Phase:
Phase I
Type:
Diagnostic, Treatment
Status:
Active
Age:
Any age
Sponsor:
Other
Protocol IDs:
4079
, NCT00671710
9.
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 months to 23 years
Sponsor:
Other
Protocol IDs:
ACH-CNS-001
, NCT00876993
10.
Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
2 to 20
Sponsor:
NCI, Other
Protocol IDs:
CDR0000543871
, SJCRH-SJBG07, NCT00472017
11.
Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment
Status:
Active
Age:
All ages
Sponsor:
Other
Protocol IDs:
URCC 11095
, NCT00178295
Select All on Page
Help with Results
